HUT36859A - Tumer-specific monoclinal antibodies - Google Patents

Tumer-specific monoclinal antibodies

Info

Publication number
HUT36859A
HUT36859A HU85344A HU34485A HUT36859A HU T36859 A HUT36859 A HU T36859A HU 85344 A HU85344 A HU 85344A HU 34485 A HU34485 A HU 34485A HU T36859 A HUT36859 A HU T36859A
Authority
HU
Hungary
Prior art keywords
tumer
monoclonal antibodies
specific
relates
diagnostic procedures
Prior art date
Application number
HU85344A
Other languages
English (en)
Other versions
HU209519B (en
Inventor
Michael Hanna
Martin Haspel
Herbert Hoover
Original Assignee
Litton Bionetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24300700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT36859(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc
Publication of HUT36859A publication Critical patent/HUT36859A/hu
Publication of HU209519B publication Critical patent/HU209519B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU85344A 1984-01-31 1985-01-30 Process for preparing monoclonal antibodies having specificity for tumor, hybridomas produced them and vaccines HU209519B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57553384A 1984-01-31 1984-01-31

Publications (2)

Publication Number Publication Date
HUT36859A true HUT36859A (en) 1985-10-28
HU209519B HU209519B (en) 1994-06-28

Family

ID=24300700

Family Applications (1)

Application Number Title Priority Date Filing Date
HU85344A HU209519B (en) 1984-01-31 1985-01-30 Process for preparing monoclonal antibodies having specificity for tumor, hybridomas produced them and vaccines

Country Status (15)

Country Link
EP (1) EP0151030B1 (hu)
JP (2) JPH0759518B2 (hu)
AT (1) ATE71410T1 (hu)
AU (2) AU589351B2 (hu)
CA (1) CA1340781C (hu)
DE (1) DE3585093D1 (hu)
DK (1) DK171896B1 (hu)
ES (1) ES8802621A1 (hu)
GR (1) GR850179B (hu)
HU (1) HU209519B (hu)
IE (1) IE58859B1 (hu)
IL (1) IL74156A (hu)
NZ (1) NZ210867A (hu)
PT (1) PT79894B (hu)
ZA (1) ZA85689B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319751A1 (de) * 1983-05-31 1984-12-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von gegen tumorantigene gerichteten monoklonalen antikoerpern und diese enthaltende arzneimittel
US6294172B1 (en) 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
DE3629640A1 (de) * 1986-08-30 1988-03-03 Behringwerke Ag Verwendung monoklonaler antikoerper zur therapie von tumoren
US5011684A (en) * 1985-09-05 1991-04-30 Beth Israel Hospital Association Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
JPS6283898A (ja) * 1985-10-09 1987-04-17 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺腺癌特異的単クロ−ン性抗体
EP0222360A3 (en) * 1985-11-12 1989-03-15 Biotherapeutics Inc. A method of producing a patient-specific cytotoxic reagent and composition
JPS62207298A (ja) * 1986-03-06 1987-09-11 Kyowa Hakko Kogyo Co Ltd 抗ヒト胃癌単クロ−ン性抗体
JPH06100843B2 (ja) * 1986-06-23 1994-12-12 キヤノン株式会社 絶縁性磁性乾式現像剤
EP0265156A3 (en) * 1986-10-14 1990-08-29 Bunge (Australia) Proprietary Limited Monoclonal antibodies
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
ATE137674T1 (de) * 1987-07-02 1996-05-15 Akzo Nobel Nv Von mca 16-88 erkanntes antigen
US5215913A (en) 1987-11-30 1993-06-01 Roger Williams General Hospital IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
DE3909799A1 (de) 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
DE69007430T2 (de) * 1989-06-19 1994-07-07 Akzo Nobel Nv Radioimmuntherapie unter alphapartikelausstrahlung.
CA2079601A1 (en) * 1990-04-12 1991-10-13 Nicholas Pomato Ctaa 28a32, the antigen recognized by mca 28a32
EP0537222A1 (en) * 1990-07-03 1993-04-21 Akzo N.V. Immunoreactive compound
US5281710A (en) * 1990-08-01 1994-01-25 The Scripps Research Institute Dynemicin analogs: synthesis, methods of preparation and use
ATE183546T1 (de) * 1991-05-16 1999-09-15 Perimmune Holdings Inc Tumorspezifischer monoklonaler antikörper 81av78
IL103758A (en) * 1991-12-13 1998-07-15 Akzo Nv Cancer-specific monoclonal antibodies
JPH06113831A (ja) * 1992-04-08 1994-04-26 Dev Center For Biotechnol ハイブリドーマおよびその抗体
EP0650735A3 (en) * 1993-07-09 1999-04-14 Akzo Nobel N.V. Kit and method for pretargeting
EP1567175B1 (en) 2002-02-22 2009-01-21 Intracel Recources LLC Sterile immunogenic non-tumorigenic tumor cell compositions and methods
US7176022B2 (en) * 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
JP2017502983A (ja) * 2013-10-02 2017-01-26 スリ テクノロジーズ エルティーディー． 不均一な腫瘍を処置するための患者特異的免疫療法
EP3409297A1 (en) 2017-05-30 2018-12-05 AlfaRim Medial Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy
US20200230266A1 (en) 2017-09-20 2020-07-23 Alfarim Medical Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58201994A (ja) * 1982-05-21 1983-11-25 Hideaki Hagiwara 抗原特異的ヒト免疫グロブリンの生産方法
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells

Also Published As

Publication number Publication date
JPH06315395A (ja) 1994-11-15
ES8802621A1 (es) 1988-09-16
DK40885A (da) 1985-10-25
ZA85689B (en) 1986-04-30
EP0151030A2 (en) 1985-08-07
DK40885D0 (da) 1985-01-30
NZ210867A (en) 1989-01-06
AU4736789A (en) 1990-05-03
CA1340781C (en) 1999-10-12
JPH0759518B2 (ja) 1995-06-28
IE850192L (en) 1985-07-31
IL74156A (en) 1990-08-31
JP2516731B2 (ja) 1996-07-24
IL74156A0 (en) 1985-04-30
ATE71410T1 (de) 1992-01-15
IE58859B1 (en) 1993-11-17
JPS60260597A (ja) 1985-12-23
DK171896B1 (da) 1997-08-04
PT79894A (en) 1985-02-01
GR850179B (hu) 1985-05-23
ES539987A0 (es) 1988-09-16
AU3799285A (en) 1985-08-08
PT79894B (en) 1986-10-23
EP0151030A3 (en) 1987-11-25
DE3585093D1 (de) 1992-02-20
AU635511B2 (en) 1993-03-25
EP0151030B1 (en) 1992-01-08
HU209519B (en) 1994-06-28
AU589351B2 (en) 1989-10-12

Similar Documents

Publication Publication Date Title
GR850179B (hu)
ZA833686B (en) Human human hybridomas for cervical carcinoma
IL80231A (en) Monoclonal anti-human breast cancer antibodies and hybridomas producing them,and diagnosis of human breast tumors
MX9705349A (es) Anticuerpo monoclonal 1a7 y su uso para el tratamiento de melanona y carcinoma de celulas pequeñas.
ATE71225T1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
EP0328578A4 (en) ANTIGEN IDENTIFIED BY MCA 16-88.
EP0440689A4 (en) Anti-idiotypic antibody induction of antitumor response
FI935038A0 (fi) Tumoer associerad monoklonal antikropp 81AV78
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
Ferrone et al. Active Specific Immunotherapy of Malignant Melanoma with Anti‐idiotypic Monoclonal Antibodies
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
ZA878077B (en) Murine hybridoma lym-2 and diagnostic antibody produced thereby

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: INTRACEL NETHERLANDS, B.V., NL

HMM4 Cancellation of final prot. due to non-payment of fee